Wells Fargo On Pace for Highest Close Since February 2022 — Data Talk
Wells Fargo & Company (WFC) is currently at $58.60, up $1.43 or 2.49%
--Would be highest close since Feb. 10, 2022, when it closed at $59.05
--On pace for largest percent increase since Feb. 15, 2024, when it rose 7.23%
--Currently up three of the past four days
--Currently up two consecutive days; up 3.89% over this period
--Best two day stretch since the two days ending Feb. 16, 2024, when it rose 6.96%
--Up 1.11% month-to-date
--Up 19.07% year-to-date
--Down 11.11% from its all-time closing high of $65.93 on Jan. 26, 2018
--Up 40.64% from 52 weeks ago (April 20, 2023), when it closed at $41.67
--Would be a new 52-week closing high
--Up 59.6% from its 52-week closing low of $36.72 on May 4, 2023
--Traded as high as $59.13; highest intraday level since Feb. 15, 2022, when it hit $59.32
--Up 3.41% at today's intraday high; largest intraday percent increase since Feb. 15, 2024, when it rose as much as 8.08%
All data as of 1:48:11 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 18, 2024 14:04 ET (18:04 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
CVS Earnings: Weak Medicare Advantage Profits Cut Into 2024 Outlook
-
Amazon Earnings: AWS Growth Accelerates and Profit Margins Improve
-
SiriusXM Earnings: Decent Results With Plan for Technology and Content Investment to Drive Growth
-
Coca-Cola Earnings: Solid Volume On Innovation and Digital Engagement
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry
-
Why the End of Quantitative Tightening Matters
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins